Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

Q&A and summary

Lecture Time
12:45 - 13:00
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2